Form 4: Milestone Pharmaceuticals Director Joseph C. Papa Acquires Stock Options

Director Joseph C. Papa acquired stock options for 80,000 common shares of Milestone Pharmaceuticals Inc. on September 3, 2024.

Summary

• On September 3, 2024, Joseph C. Papa, a director of Milestone Pharmaceuticals Inc., acquired stock options.
• The options grant the right to buy 80,000 common shares at an exercise price of $1.39.
• The options vest in equal monthly installments over three years, starting October 3, 2024, contingent upon continued service.
• The options expire on September 3, 2034.
• Following the transaction, Papa directly owns 80,000 derivative securities.

Sentiment

Score: 6

Explanation: The document itself is neutral, simply reporting a transaction. The sentiment is slightly positive as it indicates alignment of the director's interests with the company's performance.

Positives

• The acquisition of stock options by a director may signal confidence in the company's future performance.

Future Outlook

The vesting schedule indicates a long-term incentive for the director to remain with the company and contribute to its success over the next three years.

Industry Context

Stock option grants are a common form of executive compensation in the pharmaceutical industry, aligning management's interests with those of shareholders.

Stakeholder Impact

• The transaction could have a slightly positive impact on shareholders if it motivates the director to improve company performance.

Key Dates